Form 4: Herbalife Director Donal Mulligan Awarded 11,879 RSUs

Herbalife Ltd. director Donal L. Mulligan has been granted 11,879 restricted stock units as part of the company's long-term incentive compensation strategy.

Summary

• Donal L. Mulligan, a Director at Herbalife Ltd., acquired 11,879 restricted stock units (RSUs) on May 8, 2026.
• The RSUs were granted at a price of $0.00 as part of the company's Amended and Restated 2023 Stock Incentive Plan.
• Following this transaction, Mulligan directly owns 68,982 shares of common stock.
• Mulligan also maintains an indirect ownership of 60,000 shares held by a trust.
• The newly granted RSUs are scheduled to vest 100% on April 15, 2027, contingent upon continued service on the Board of Directors.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a standard, neutral-to-positive governance event. While it is a routine grant, the increase in insider equity exposure is generally viewed favorably by the market.

Positives

• Increased insider ownership demonstrates alignment between board members and shareholders.
• The reporting person holds a significant total stake of 128,982 shares (direct and indirect combined).
• The use of a vesting period (until April 15, 2027) encourages long-term retention and strategic oversight.

Negatives

• The grant is a non-cash compensation expense for the company, which can lead to minor share dilution upon vesting.

Risks

• Vesting is subject to the director's continued service, posing a risk of forfeiture if the director leaves the board before April 15, 2027.
• The ultimate value of the award is entirely dependent on the market price of HLF common stock at the time of vesting.

Future Outlook

The grant ensures that a key member of the board remains incentivized to drive company performance through at least mid-2027, aligning management's interests with the long-term stock price appreciation.

Management Comments

• The RSUs will vest 100% on April 15, 2027, subject to continued service on the Issuer's Board of Directors through such date.

Industry Context

StockSavvy.ai notes that equity-based compensation for non-employee directors is a standard practice among mid-cap consumer goods companies like Herbalife to conserve cash while ensuring board members have 'skin in the game' alongside public investors.

Comparison to Industry Standards

• The grant size is consistent with director compensation packages at peer health and wellness companies such as USANA Health Sciences and Nu Skin Enterprises.
• A one-year cliff vesting period is a common benchmark for annual director equity awards in the S&P 400 and 600 indices.

Corporate Governance

Stakeholder Impact

• Shareholders: Positive alignment as directors are compensated based on stock performance.
• Management: Stability in the board of directors through the 2027 vesting period.

Next Steps

• Monitoring for the vesting of these units on April 15, 2027.
• Observation of any subsequent open-market purchases or sales by the reporting person.

Key Dates

Recommendation

This filing represents a routine administrative grant of equity to a director. While it shows continued commitment from the board, it does not provide new material information regarding the company's operational performance or financial health that would trigger a change in investment rating.

Keywords

Herbalife, HLF, Insider Trading, Form 4, Restricted Stock Units, Donal Mulligan, Director Compensation, Equity Grant